The effect of pindolol on plasma renin activity in patients with essential hypertension.
Twenty-two patients with essential hypertension were treated for 3 months with pindolol, and blood pressure and plasma renin activity were measured at rest and after stimulation (upright posture stimulation and insulin induced hypoglycaemia stimulation). Beta-receptor blockade produced a significant decrease in systolic and diastolic blood pressure. After treatment with pindolol the plasma renin activity was significantly lower. Under conditions of renin stimulation such as orthostasis and insulin produced hypoglycaemia, plasma renin activity was significantly lower in treated patients. There was no correlation between the fall of plasma renin activity and the decrease of blood pressure. Renin suppression is probably only one of the factors involved in the reduction in the blood pressure in these patients.
D000293:Adolescent; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000097:blood; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced / Q000150:complications; D007328:Insulin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000494:pharmacology* / Q000627:therapeutic use; D011187:Posture; D011188:Potassium / Q000097:blood; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000097:blood; D013997:Time Factors
D002395:Catecholamines; D007328:Insulin; D012964:Sodium; D010869:Pindolol; D012083:Renin; D011188:Potassium